Education
About Us
Working with TipRanks
Follow Us
CANbridge Pharmaceuticals Inc. (HK:1228)
:1228
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 85.10M | ¥ 102.87M | ¥ 78.97M | ¥ 31.16M | ¥ 12.03M |
| Gross Profit | ¥ 54.30M | ¥ 64.16M | ¥ 48.89M | ¥ 18.78M | ¥ 6.88M |
| Operating Income | ¥ -340.51M | ¥ -366.55M | ¥ -477.05M | ¥ -1.12B | ¥ -821.50M |
| EBITDA | ¥ -328.69M | ¥ -341.43M | ¥ -454.63M | ¥ -1.06B | ¥ -824.41M |
| Net Income | ¥ -442.62M | ¥ -378.84M | ¥ -483.48M | ¥ -1.08B | ¥ -846.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 10.50M | ¥ 137.49M | ¥ 451.16M | ¥ 745.82M | ¥ 360.80M |
| Total Assets | ¥ 116.81M | ¥ 395.36M | ¥ 702.04M | ¥ 892.52M | ¥ 586.36M |
| Total Debt | ¥ 135.78M | ¥ 141.93M | ¥ 155.28M | ¥ 52.10M | ¥ 46.90M |
| Net Debt | ¥ 125.28M | ¥ 17.03M | ¥ -295.88M | ¥ -693.71M | ¥ -313.91M |
| Total Liabilities | ¥ 591.30M | ¥ 435.15M | ¥ 393.49M | ¥ 199.13M | ¥ 2.33B |
| Stockholders' Equity | ¥ -474.49M | ¥ -39.79M | ¥ 308.56M | ¥ 693.39M | ¥ -1.75B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -122.50M | ¥ -319.09M | ¥ -315.76M | ¥ -592.40M | ¥ -305.13M |
| Operating Cash Flow | ¥ -122.39M | ¥ -278.23M | ¥ -280.98M | ¥ -587.07M | ¥ -151.65M |
| Investing Cash Flow | ¥ 13.93M | ¥ -26.86M | ¥ -34.79M | ¥ 126.09M | ¥ -153.48M |
| Financing Cash Flow | ¥ -18.57M | ¥ -28.02M | ¥ -20.70M | ¥ 854.31M | ¥ 679.26M |
CANbridge Pharmaceuticals Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.